AI assistant
Sending…
Arctic Bioscience — AGM Information 2021
Nov 10, 2021
3536_rns_2021-11-10_31820bb9-f8ae-4255-8f44-ce76b0f4adb8.pdf
AGM Information
Open in viewerOpens in your device viewer
Totalt representert
| I ISIN: I | NO0010859580 ARCTIC BIOSCIENCE AS |
|---|---|
| Generalforsamlingsdato: 10.11.2021 13.00 | |
| Dagens dato: | 10.11.2021 |
Antall stemmeberettigede personer representert/oppmøtt : 1
| Antall aksjer | % kapital | |
|---|---|---|
| Total aksjer | 24 299 539 | |
| - selskapets egne aksjer | 0 | |
| Totalt stemmeberettiget aksjer | 24 299 539 | |
| Representert ved forhåndsstemme | 7 424 638 | 30,56 % |
| Sum Egne aksjer | 7424638 | 30,56 % |
| Representert ved fullmakt | 1 314 290 | 5,41 % |
| Representert ved stemmeinstruks | 1 408 784 | 5,80 % |
| Sum fullmakter | 2723074 | 11,21% |
| Totalt representert stemmeberettiget | 10 147 712 | 41,76 % |
| Totalt representert av AK | 10 147 712 | 41,76 % |
Kontofører for selskapet:
For selskapet:
DNB Bank ASA
ARCTIC BIOSCIENCE AS
Total Represented
| I ISIN: I | NO0010859580 ARCTIC BIOSCIENCE AS |
|---|---|
| General meeting date: 10/11/2021 13.00 | |
| Today: | 10.11.2021 |
Number of persons with voting rights represented/attended: 1
| Number of shares % sc | ||
|---|---|---|
| Total shares | 24,299,539 | |
| - own shares of the company | 0 | |
| Total shares with voting rights | 24,299,539 | |
| Represented by advance vote | 7,424,638 | 30.56 % |
| Sum own shares | 7,424,638 | 30.56 % |
| Represented by proxy | 1,314,290 | 5.41% |
| Represented by voting instruction | 1,408,784 | 5.80% |
| Sum proxy shares | 2,723,074 11.21 % | |
| Total represented with voting rights | 10,147,712 41.76 % | |
| Total represented by share capital | 10,147,712 41.76 % |
Registrar for the company:
Signature company:
DNB Bank ASA
ARCTIC BIOSCIENCE AS
Y-,/,%,))=,-1(:(-*)=,-&*6)2:1\$]G4]^4_5]4X]\$5
| !!" | |
| # | !! |
| !!" | ||||||
| # | !! | |||||
| \$%&'(%)*&&( | +,- | .,/ | \$012//( | \$0&/3- | 4%%(*012// | 5/(66(7(-(//21(8( -(9-(&(:/(-/(*%&'(- |
| 5%;<9:2:101(:(-)=,-&6)2:1(:0(8&/>-(/&)(8(- | ||||||
| ? | " @! |
" @! |
A@@! | |||
| BC | DB | DB | DB | |||
| BE?F | D !B |
DB | D !B |
DB | DB | |
| B?F | AD@"B | DB | AD@"B | D"B | DB | |
| G,/*)/ | ;H;IJK;L | H | ;H;IJK;L | MHHH | H | ;H;NKK;L |
| 5%LO)1*06P/()(8(-,1(:9(-&,:/2)36(8Q:8(-/(1:(9-,/,%,))(: | ||||||
| ? | " @! |
" @! |
A@@! | |||
| BC | DB | DB | DB | |||
| BE?F | D !B |
DB | D !B |
DB | DB | |
| B?F | AD@"B | DB | AD@"B | D"B | DB | |
| G,/*)/ | ;H;IJK;L | H | ;H;IJK;L | MHHH | H | ;H;NKK;L |
| 5%IR,8%'(::2:102::%))2:1,181&,-8(: | ||||||
| ? | " @! |
" @! |
A@@! | |||
| BC | DB | DB | DB | |||
| BE?F | D !B |
DB | D !B |
DB | DB | |
| B?F | AD@"B | DB | AD@"B | D"B | DB | |
| G,/*)/ | ;H;IJK;L | H | ;H;IJK;L | MHHH | H | ;H;NKK;L |
| 5%NO)1*0:>//&/>-(6(8)(6 | ||||||
| ? | @" ! |
A@A | A@@! | A@@! | ||
| BC | SD!B | "DB | DB | |||
| BE?F | SD!B | "DB | DB | DB | DB | |
| B?F | " D SB |
DB | AD@SB | DB | DB | |
| G,/*)/ | MKIMJLM | ;NHMKMN | ;H;NKK;L | H | H | ;H;NKK;L |
FTUE
WUE
U?-
-?-
VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
| VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV X0: G,/)/:/))%&'(- Y3)>8(:8( \$%&'(%92/*) 5/(66(-(// ? !A! " D !A! "D [ |
|||
|---|---|---|---|
| \$%&'(2:=,-6*&',: | |||
| 5Q6Z |
§ 5-17 Alminnelig flertallskrav
krever flertall av de avgitte stemmer
§ 5-18 Vedtektsendring
krever tilslutning fra minst to tredeler så vel av de avgitte stemmer
som av den aksjekapital som er representert på generalforsamlingen
Protocol for general meeting ARCTIC BIOSCIENCE AS
| ISIN: | NO0010859580 ARCTIC BIOSCIENCE AS |
|---|---|
| General meeting date: 10/11/2021 13.00 | |
| Today: | 10.11.2021 |
| Shares class | FOR | Against | Poll in | Abstain Poll not registered Represented shares with voting rights |
||
|---|---|---|---|---|---|---|
| Agenda item 1 Opening of the general meeting by the chairperson of the board | ||||||
| Ordinær | 10,139,712 | 0 | 10,139,712 | 8,000 | 0 | 10,147,712 |
| votes cast in % | 100.00 % | 0.00% | 0.00% | |||
| representation of sc in % | 99.92 % | $0.00 \%$ | 99.92 % | 0.08% | 0.00% | |
| total sc in % | 41.73 % | 0.00% | 41.73 % | 0.03% | 0.00% | |
| Total | 10,139,712 | $0$ 10,139,712 | 8,000 | 0 | 10,147,712 | |
| Agenda item 2 Election of a chairperson and a person to co-sign the minutes | ||||||
| Ordinær | 10,139,712 | 0 | 10,139,712 | 8,000 | $\Omega$ | 10,147,712 |
| votes cast in % | 100.00 % | 0.00% | 0.00% | |||
| representation of sc in % | 99.92 % | $0.00 \%$ | 99.92 % | 0.08% | 0.00% | |
| total sc in % | 41.73 % | $0.00 \%$ | 41.73 % | 0.03% | 0.00% | |
| Total | 10,139,712 | 0 | 10,139,712 | 8,000 | $\mathbf 0$ | 10,147,712 |
| Agenda item 3 Approval of the notice and the agenda | ||||||
| Ordinær | 10,139,712 | $\mathbf 0$ | 10,139,712 | 8,000 | 0 | 10,147,712 |
| votes cast in % | 100.00 % | 0.00% | 0.00% | |||
| representation of sc in % | 99.92 % | 0.00% | 99.92 % | 0.08% | 0.00% | |
| total sc in % | 41.73 % | $0.00 \%$ | 41.73 % | 0.03% | 0.00% | |
| Total | 10,139,712 | 0 | 10,139,712 | 8,000 | 0 | 10,147,712 |
| Agenda item 4 Election of new board member | ||||||
| Ordinær | 8,738,928 | 1,408,784 | 10,147,712 | 0 | 0 | 10,147,712 |
| votes cast in % | 86.12 % | 13.88 % | 0.00% | |||
| representation of sc in % | 86.12 % | 13.88 % | 100.00 % | 0.00% | 0.00% | |
| total sc in % | 35.96 % | 5.80 % | 41.76 % | 0.00% | 0.00% | |
| Total | 8,738,928 1,408,784 10,147,712 | $\mathbf 0$ | 0 | 10,147,712 |
| Registrar for the company: | |||
|---|---|---|---|
Signature company:
DNB Bank ASA
ARCTIC BIOSCIENCE AS
Share information
| Name | Total number of shares Nominal value Share capital Voting rights | ||
|---|---|---|---|
| l Ordinær | 24,299,539 | $0.10$ 2,429,953.90 Yes | |
| Sum: |
§ 5-17 Generally majority requirement
requires majority of the given votes
§ 5-18 Amendment to resolution
Requires two-thirds majority of the given votes
like the issued share capital represented/attended on the general meeting
More from Arctic Bioscience
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7